International Journal of Biological Sciences

Impact factor
3.873

ISSN 1449-2288

News feeds of IJBS published articles
My Manuscript
My Account

Journal of Biomedicinenew

Theranostics

International Journal of Medical Sciences

Journal of Cancer

Oncomedicine

Journal of Genomics

Journal of Bone and Joint Infection (JBJI)

Nanotheranostics

PubMed Central Indexed in Journal Impact Factor

Int J Biol Sci 2012; 8(3):298-309. doi:10.7150/ijbs.3656

Research Paper

Pretreatment of Cisplatin in Recipients Attenuates Post-Transplantation Pancreatitis in Murine Model

Sheng Yan1, #, Yuan Ding1, #, Fei Sun1, Zhongjie Lu1, Liang Xue1, Xiangyan Liu1, Mingqi Shuai1, Chen Fang1, Yan Wang1, Hui Cheng1, Lin Zhou1, Ming H Zheng1,2,✉, Shusen Zheng1,✉

1. Division of Hepatobiliary and Pancreatic Surgery; Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health; and Key Laboratory of Organ Transplantation Zhejiang Province, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, P.R. China.
2. Centre for Orthopaedic Research, School of Surgery, University of Western Australia, Western Australia, 6009, Australia.
# These authors contributed equally to this paper.

Abstract

Pancreas transplantation is the definite treatment for type 1 diabetes that enables the achievement of long-term normoglycemia and insulin independence. However Post-Transplantation Pancreatitis (PTP) due to ischemia reperfusion (IR) injury and preservation is a major complication in pancreas transplantation. Owning the potential anti-inflammatory effect of Cisplatin (Cis) in liver IR injury, we have examined if Cis could attenuate PTP using a murine model. We found that Cis is able to prevent inflammatory response in PTP. Pretreatment of Cis in recipient mice reduce the impairments of the grafts and hyperamylasimea in the recipients. We documented that the protective mechanism of Cis in PTP involves improvement of microcirculation, reduction of the mononuclear cellular infiltration and apoptosis, suppression of inflammatory cytokine-cascade and inhibition of translocation of high-motility group box protein-1 (HMGB-1) from nucleus to cytoplasm. In short, our study demonstrated that pretreatment of Cis in recipients may reduce the onset of PTP in pancreas transplantation.

Keywords: Cisplatin, Pancreatitis, Ischemia reperfusion injury, High-motility group box protein-1, Intravital fluorescence microscopy.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Yan S, Ding Y, Sun F, Lu Z, Xue L, Liu X, Shuai M, Fang C, Wang Y, Cheng H, Zhou L, Zheng MH, Zheng S. Pretreatment of Cisplatin in Recipients Attenuates Post-Transplantation Pancreatitis in Murine Model. Int J Biol Sci 2012; 8(3):298-309. doi:10.7150/ijbs.3656. Available from http://www.ijbs.com/v08p0298.htm